Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.

Conditions: Metastatic Colorectal Cancer Interventions: Drug: Envafolimab; Drug: Trifluridine/Tipiracil; Drug: Bevacizumab Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials